Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 2, 2009, Pages 199-209

  Xing, Hui Qin ^a   Hayakawa, Hitoshi ^a,b   Gelpi, Ellen ^b   Kubota, Ryuji ^a   Budka, Herbert ^b   Izumo, Shuji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Astrocytes; Cerebral cortex; Excitatory amino acid transporter2; HIV encephalopathy; Immunohistochemistry; Microglia; Neuroprotection

Indexed keywords

ANTIGEN P24; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; GAG PROTEIN; GLUTAMATE TRANSPORTER; SLC1A2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN CORTEX; BRAIN TISSUE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GLIOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROGLIA; NEUROPATHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ENCEPHALITIS; CELL PROTECTION; DOWN REGULATION; IMMUNOLOGY; METABOLISM; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; ASTROCYTES; BIOLOGICAL MARKERS; CEREBRAL CORTEX; CYTOPROTECTION; DOWN-REGULATION; GLIOSIS; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; HIV CORE PROTEIN P24; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; MICROGLIA; NERVE DEGENERATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64049107958     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31819715df     Document Type: Article

References (44)

1. Budka H, Wiley CA, Kleihues P, et al. HIV-associated disease of the nervous system: Review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991;1:143-152
2. Gabuzda DH, Ho DD, de la Monte SM, et al. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986;20:289-295
3. Budka H, Costanzi G, Cristina S, et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol 1987;75:185-198
4. Raja F, Sherriff FE, Morris CS, et al. Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol 1997;93:184-189
5. An SF, Giometto B, Groves M, et al. Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 1997;56:1262-1268
6. Giometto B, An SF, Groves M, et al. Accumulation of beta-amyloid precursor protein in HIV encephalitis: Relationship with neuropsy-chological abnormalities. Ann Neurol 1997;42:34-40
7. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991;1:163-175
8. Wiley CA, Achim CL, Christopherson C, et al. HIV mediates a productive infection of the brain. AIDS 1999;13:2055-2059
9. Glass JD, Wesselingh SL, Selnes OA, et al. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230-2237
10. Gray F, Scaravilli F, Everall I, et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996;6:1-15
11. Ketzler S, Weis S, Haug H, et al. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol (Berl) 1990;80:92-94
12. Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991;337:1119-1121
13. Aylward EH, Henderer JD, McArthur JC, et al. Reduced basal ganglia volume in HIV-1Yassociated dementia: Results from quantitative neuro-imaging. Neurology 1993;43:2099-2104
14. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001;410:988-994
15. Wiley CA, Masliah E, Morey M, et al. Neocortical damage during HIV infection. Ann Neurol 1991;29:651-657
16. Masliah E, Ge N, Morey M, et al. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 1992;66: 285-291
17. Masliah E, Heaton RK, Marcotte TD, et al. Dendritic injury is a pathological substrate for human immunodeficiency virusYrelated cognitive disorders. Ann Neurol 1997;42:963-972
18. Xing HQ, Moritoyo T, Mori K, et al. Simian immunodeficiency virus encephalitis in the white matter and degeneration of the cerebral cortex occur independently in simian immunodeficiency virus-infected monkey. J Neurovirol 2003;9:508-518
19. Xing HQ, Mori K, Sugimoto C, et al. Impaired astrocytes and diffuse activation of microglia in the cerebral cortex in simian immunodefi-ciency virusYinfected macaques without SIV encephalitis. J Neuropathol Exp Neurol 2008;67:600-611
20. Gray F, Haug H, Chimelli L, et al. Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encepha-lopathy. Acta Neuropathol 1991;82:229-233
21. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995;146:1121-1130
22. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-622
23. Arriza JL, Fairman WA, Wadiche JI, et al. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 1994;14:5559-5569
24. Tanaka K, Watase K, Manabe T, et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter EAAT-2. Science 1997;276:1699-1702
25. Martin LJ, Brambrink AM, Lehmann C, et al. Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann Neurol 1997;42:3335-3348
26. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001;65:1-105
27. Wang Z, Pekarskaya O, Bencheikh M, et al. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 2003; 312:60-73
28. Toggas SM, Masliah E, Rockenstein EM, et al. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994;367:188-193
29. Brenneman DE, Westbrook GL, Fitzgerald SP, et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988;335:639-642
30. Bagetta G, Corasaniti MT, Aloe L, et al. Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc Natl Acad Sci U S A 1996; 93:928-933
31. Meucci O, Fatatis A, Simen AA, et al. Chemokines regulate hippo-campal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A 1998;95:14500-14505
32. Jones M, Olafson K, Del Bigio MR, et al. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J Neuropathol Exp Neurol 1998;57:563-570
33. Shi B, Raina J, Lorenzo A, et al. Neuronal apoptosis induced by HIV-1 Tat protein and TNFalpha: Potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J Neurovirol 1998; 4:281-290
34. Jana A, Pahan K. Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase. J Neurosci 2004; 24:9531-9540
35. Boycott HE, Wilkinson JA, Boyle JP, et al. Differential involvement of TNF-alpha in hypoxic suppression of astrocytes glutamate transporters. Glia 2008;56:998-1004
36. Kreutzberg GW. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-318
37. Genis P, Jett M, Bernton EW, et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)Yinfected macrophages-astroglia interactions: Implications for the neuropathogenesis of HIV disease. J Exp Med 1992;176: 1703-1718
38. Tyor WR, Glass JD, Griffin JW, et al. Cytokine expression in the brain during acquired immunodeficiency syndrome. Ann Neurology 1992;31: 49-60
39. Epstein LG, Gendelman HE. Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms. Ann Neurol 1993;33:429-436
40. Nakajima K, Honda S, Tohyama Y, et al. Neurotrophin secretion from cultured microglia. J Neurosci Res 2001;65:322-331
41. Vallat-Decouvelaere AV, Chretien F, Gras G, et al. Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients: A neuroprotective role for activated microglia? J Neuropathol Exp Neurol 2003;62:475-485
42. Gras G, Chretien F, Vallat-Decouvelaere AV, et al. Regulated expression of sodium-dependent glutamate transporters and synthetase: A neuro-protective role for activated microglia and macrophages in HIV infection? Brain Pathol 2003;13:211-222
43. Gray F, Adle-Biassette H, Levy Y, et al. Neuronal apoptosis in the course of human immunodeficiency virus infection. Bull Acad Natl Med 1996;180:1855-1867; [discussion 1867-68]
44. Adle-Biassette H, Wingertsmann L, Authier FJ, et al. Neuronal apoptosis in the central and peripheral nervous system in HIV infection. Arch Anat Cytol Pathol 1997;45:86-93